Medical Research News

RSS

New viral insights lay foundation for treating infection with JC polyomaviruses

In people with severely compromised immune systems, the JC polyomavirus can trigger a currently untreatable, usually fatal brain disease.

6 Jul 2026

New HIV vaccine successfully generates broadly neutralizing antibodies in primates

A new HIV vaccine developed by La Jolla Institute for Immunology (LJI), Scripps Research scientists, and IAVI has the potential to protect humans from developing HIV infection and AIDS.

6 Jul 2026

Study identifies promising drug target to prevent neurodegenerative conditions

Parkinson's disease (PD) is the second most common form of neurodegenerative disease and afflicts more than ten million people worldwide. While current therapies address disease symptoms, they do not prevent the underlying neurodegeneration that drives the disease.

6 Jul 2026

New conceptual model links sacred moments to clinician well-being

In health care, it is often the smallest moments that carry the greatest meaning - a quiet conversation with a patient, a shared reflection with colleagues, or a hand held in silence.

6 Jul 2026

Study compares different light therapies for treating Alzheimer's disease

The researchers treated 5‑month‑old 5xFAD mice – a model with aggressive amyloid deposition – with 810‑nm light (25 mW/cm² at the scalp, ~6.25 mW/cm² brain dose for CW, and half that for 40‑Hz due to 50% duty cycle) for 10 minutes daily over 37 days.

6 Jul 2026

Study finds specialized gambling addiction services underused in Quebec

A new study finds public specialized gambling addiction treatment services are underused in Quebec, pointing to a need to better reach people with gambling disorder.

6 Jul 2026

Study explores the relationship between heart issues and cognitive function

New in JNeurosci, Xia Zhang, from the Max Planck Institute for Human Cognitive and Brain Sciences, led a study exploring the relationship between heart issues and cognitive function.

6 Jul 2026

Study reveals unexpected movement of drug-delivery swimming robots

One day, tiny swimming robots may travel through the human body to deliver drugs. The medication would target only areas of need-chemotherapy drugs for a tumor, for example-avoiding healthy tissue and minimizing side effects.

6 Jul 2026

Researchers identify a distinct subtype of eosinophilic esophagitis in children

Researchers from Ann & Robert H. Lurie Children's Hospital of Chicago identified a distinct subtype of eosinophilic esophagitis (EoE) – a chronic allergic inflammatory disorder in which the esophagus narrows, interfering with food going down properly.

6 Jul 2026

Study tracks why rural residents face higher chronic disease risks

Following the release of data from Assumption Parish earlier this year, researchers at LSU's Pennington Biomedical Research Center have published the first set of data from the Risks Underlying Rural Areas Longitudinal, or RURAL, Heart and Lung study in Franklin Parish. The data book for Franklin Parish is now available to explore.

6 Jul 2026

Men face higher risk of late-stage cancer diagnoses than women

Between 2015 and 2022, men were more likely than women to be diagnosed with regional and/or distant stages of 20 nonreproductive solid cancer types in the United States, according to a study published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research (AACR).

6 Jul 2026

McMaster researchers uncover why statins cause painful muscle side effects

Millions of people rely on statins - a medication used to lower cholesterol and reduce the risk of heart attack and stroke.

6 Jul 2026

Anti-lipid antibodies could improve early testing for Lyme disease

Lyme disease can be easiest to treat in its earliest stages, but current tests often miss infections during that critical window and cannot tell whether bacteria are still present or were cleared years ago.

6 Jul 2026

Engineered immune cells suppress asthma symptoms in allergic mice

Genetically engineered CAR T cells expressing artificial receptor proteins are increasingly used in the clinic to boost the immune system's response against leukemias and other cancers.

6 Jul 2026

Rumination carries anxiety into deeper distress for caregivers of dementia patients

A new study from Virginia Tech suggests patterns of repetitive negative thinking explain how anxiety develops into deeper stress for caregivers of people living with dementia, and that mindfulness training may help identify and interrupt that progression.

6 Jul 2026

Lifelong violence against women linked to significantly earlier menopause

The research, published in the journal Maturitas, links trauma experienced to the onset of the menopause up to 20 months earlier and an increase in hot flushes, depression and cardiometabolic health problems.

6 Jul 2026

Persistent disparities found in preventive cancer care for sexual and gender minority populations

New research has uncovered persistent disparities in preventive cancer care across different sexual orientation and gender identity (SOGI) populations.

6 Jul 2026

New study highlights noninvasive biomarkers for colorectal cancer detection

Emerging discoveries in liquid biomarker research promise to transform early detection, diagnosis, and treatment monitoring of colorectal cancer (CRC), according to a new study, offering less invasive alternatives to traditional methods that often require surgical interventions or tissue biopsies.

6 Jul 2026

Study provides new insights into biological processes linked to Huntington’s disease

A study conducted by the Sant Pau Research Institute (IR Sant Pau) and Hospital de Sant Pau has identified for the first time in living individuals a brain pattern related to the tau protein that changes according to the stage of Huntington's disease.

6 Jul 2026

ReproNovo announces first participant dosed in EU Phase 2 trial of RPN-002 for embryo implantation

ReproNovo, a clinical-stage biopharmaceutical company committed to addressing critical gaps in male and female fertility as well as women’s health, today announced that the first participant has been dosed in the Company’s EU Phase 2 clinical trial of RPN-002, entitled Nolasiban Optimized Regimen Dosing for Inhibition of Uterine Contractility (NORDIC).

6 Jul 2026